期刊文献+

长春碱PCL-PEG-PCL纳米粒的制备及质量评价 被引量:4

Preparation and evaluation of vinblastine PCL-PEG-PCL nanoparticles
下载PDF
导出
摘要 目的:制备负载长春碱的PCL-PEG6000-PCL纳米粒,并研究其理化性质及体外抗肿瘤活性。方法:采用开环聚合法制备PCL-PEG6000-PCL三嵌段元共聚物,通过共沉淀法制备了长春碱的PCL-PEG6000-PCL纳米粒,并测定其形态、粒径及多分散度、粒子产率、载药率和包封率、体外释放度,采用MTT法考察长春碱纳米粒对人白血病细胞耐药株K562/A02的细胞毒性。结果:透射电镜结果表明:得到了具有核-壳结构的球形粒子,并且纳米粒的平均粒径为(185±2.7)nm,载药率和包封率分别为28.83%和86.52%,体外释放研究表明:长春碱从纳米粒中的释放量(9h)达70%以上,24h释放基本完全。负载长春碱的纳米粒对K562/A02的抑制率比同浓度下长春碱溶液组显著增加。结论:PCL-PEG-PCL纳米粒可以作为长春碱的载体,所得粒子形状规则,包封率高,性质稳定,药物释放缓慢。长春碱经过PCL-PEG-PCL纳米粒的包裹后,对K562/A02的细胞毒性显著增强。 Aim:To prepare vinblastine-loaded PCL-PEG6000-PCL nanoparticles,and to study their physicochemical properties and in vitro antitumor activity.Methods:PCL-PEG6000-PCL triblock copolymer was prepared by ring-opening polymerization,and vinblastine-loaded PCL-PEG6000-PCL nanoparticles was prepared by coprecipitation.The morphous,particle size,polydisperse index,particle yield,the drug-loading content,the encapsulation efficiency and in vitro release rate of these vinblastine-loaded nanoparticles were determined.The cytotoxicity of vinblastine-loaded nanoparticles to K562/A02 leukimia cell line was determined by MTT assay.Results:It was found using transmission electron microscopy(TEM)that the nanoparticles exhibited a spherical shape with core-shell structure.The particle sizes of the nanoparticles obtained by dynamic light scattering were(185±2.7)nm.The drug loading content and the encapsulation efficiency were determined to be 28.83% and 86.52%,respectively.In vitro release study revealed that more than 70% of accumulative release of entrapped vinblastine was reached in 9 hr and that nearly complete release was achieved in 24 hr.The inhibition of vinblastine-loaded nanoparticles to K562/A02 cell line was significantly increased as compared with that of the same dose of sulfate vinblastine solution.Conclusions:PCL-PEG-PCL nanoparticles could be used as a carrier of vinblastine,and the prepared nanoparticles exhibited a spherical shape,high encapsulation efficiency,relevant stablity and sustained-release properties.The cytotoxicity of vinblastine to K562/A02 cell line was significantly increased when it was encapsulated in PCL-PEG-PCL nanoparticles.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2010年第1期29-34,共6页 Journal of China Pharmaceutical University
基金 国家自然科学基金重点资助项目(No.30430790) 国家"重大新药创制"科技重大专项资助项目(No.2009ZX09310-004)~~
关键词 长春碱 PCL-PEG-PCL 纳米粒 制备 抗肿瘤活性 vinblastine PCL-PEG-PCL nanoparticle preparation antitumor activity
  • 相关文献

参考文献16

  • 1江苏新医学院.中药大词典[M].上海:上海科学技术出版社,1986.586-589.
  • 2Vander HR, Jacobs DI, Snoeijer W, et al. The Catharus alkaloids : pharmacognosy and biotechnology [ J ]. Cur Med Chem, 2004,11(5) :607 -608.
  • 3Wan CK,Zhu GY,Shen XL,et al. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells [ J ]. Biochem Pharmacol, 2006,72 (7) :824 -837.
  • 4Hu Y, Zhang L, Cao Y,et al. Degradation behavior of poly ( ε-caprolactone) -b-poly ( ethyleneglycol ) -b-poly ( ε-caprolactone ) micelles in aqueous solution [J]. Biomacromolecules, 2004,5 (5):1 756-1 762.
  • 5Petrak K. Design and properties of particulate carriers for intravascular administration [ J ]. Drug Pharm Sci, 1993,61 ( 2 ) :275 - 297.
  • 6Allen TM. The use of glycolipids and hydrophilic polymers in avoiding rapid-take of liposomes by the mononuclear phagocyte system [ J ]. Adv Drug Deliv Rev, 1994,13 ( 3 ) : 185 - 309.
  • 7Bazile D, Prudhomme C, Bassoullet MT, et al. Stealth MePEGPLA nanoparticles avoid uptake by the mononuclear phagocytes system[J]. J Pharm Sci,1995,84(4) :493 -498.
  • 8Kataoka K, Kwon GS, Yokoyama M, et al. Block copolymer micelles as vehicles for drug delivery [ J ]. J Control Release, 1993, 24(1-3) :119 -132.
  • 9Shin IG, Kim SY, Lee YM, et al. Methoxy poly (ethylene glycol)/e-caprolactone amphiphilic block copolymeric micelle con- taining indomethacin. Ⅰ. Preparation and characterization [ J ]. J Control Release, 1998,51 ( 1 ) : 1 - 11.
  • 10Hu Y,Jiang XQ,Ding Yet al. Preparation and drug release behaviors of nimodipine-loaded poly ( caprolactone ) -poly ( ethylene oxide ) -polylactide amphiphilic copolymer nanoparticles [ J ]. Biomaterials ,2003,24 ( 13 ) :2 395 - 2 404.

二级参考文献10

共引文献70

同被引文献30

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部